• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Obstruction/Occlusion (2422); Restenosis (4576)
Event Date 05/07/2021
Event Type  Injury  
Manufacturer Narrative
A1: no patient specific details have been provided.Therefore, the patient initials reflect the w.L.Gore internal case number.C1: heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.H6 code b14: a review of the manufacturing records couldn't be performed because the serial number is unknown.H3 and h6 code b20: the device remains implanted in the patient.Therefore a device evaluation could not be performed.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
Reportedly on (b)(6) 2021, this patient underwent an endovascular repair of a thoracoabdominal aneurysm ii which was treated with a fenestrated and branched stent graft component.During the procedure planning, it was determined that the celiac trunk, superior mesenteric artery, right and left renal artery will be incorporated in the fenestrated and branched endograft.A gore® viabahn® vbx balloon expandable endoprosthesis were implanted in the celiac trunk.Reportedly, the whole procedure was eventful, aortic access was successfully gained, however the device was not deployed as intended.The catheters were successfully removed and the patency of the device was patent at the end of the procedure.The patient received an additional antiplatelet medication during the procedure.According to reports, on (b)(6) 2022, during a clinical follow a computed tomography angiography was performed and it was discovered that the celiac trunk was occluded unintentionally by a vbx.Reportedly it was mentioned that the vbx was stuck in the native stenosis of the celiac trunk.The physician indicated that they didn't realize this during the removal of the catheter because they thought that the stent was still on the balloon, because the balloon for the vbx is white (same color as the stent).The physician emphasized that the stent was not taken out, instead it was stuck in the stenosis of the celiac trunk as a plug.Reportedly on (b)(6) 2023, a repeat intervention was performed.Additionally, the physician indicated that a persistent type ii endoleak remained from the celiac (via the sma).The celiac trunk was retrogradely accessed and coil embolized thus treating the endoleak.
 
Manufacturer Narrative
A1: no patient specific details have been provided.Therefore, the patient initials reflect the associated study number.Emdr section h6 codes updated to reflect results of investigation.
 
Manufacturer Narrative
Emdr section h6: codes updated to reflect results of investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
samir kulovic
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key17341020
MDR Text Key319397143
Report Number2017233-2023-04120
Device Sequence Number1
Product Code PRL
Combination Product (y/n)Y
Reporter Country CodeDA
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 02/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/18/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age73 YR
Patient SexMale
-
-